期刊文献+

曲马多超前镇痛在腹腔镜胆囊切除术中的应用 被引量:3

Evaluation of the effect of preemptive analgesia intravenous tramadol hydrochloride in patients undergoing laparoscopic cholecystectomy
下载PDF
导出
摘要 目的探讨曲马多超前镇痛对腹腔镜胆囊切除术病人的影响。方法选择全麻病人60例,随机分为C组(对照组,n=30)、T组(曲马多组,n=30)。术中切实补足血容量。试验组手术前15min静脉注射曲马多100mg(10ml),对照组注射生理盐水10ml作为对照。记录术后1、2、4、6、12和24h视觉模拟评分(VAS)。结果试验组VAS明显低于对照组(P<0.05)。结论曲马多超前镇痛对腹腔镜胆囊切除术病人产生较好的镇痛效果。 Objective To investigate the preemptive analgesia of intravenous tramadol in patients undergoing laparoscopic cholecystectomy.Methods 60 ASAⅠorⅡpatients undergoing laparoscopic cholecystectomy under general anaesthesia were randomly divided into two groups(thirty cases/group).In test group tramadol hydrochloride 100mg(10ml) was administrated 15min before operation.The visual analogue scale(VAS) in 1,2,4,6,12,24h after operation were obtained.Results The VAS of test group were markedly lower than control group(P0.05).Conclusion Intravenous tramadol hydrochloride 100mg provide reliable preemptive analgesia in laparoscopic cholecystectomy.
出处 《西部医学》 2012年第2期332-333,共2页 Medical Journal of West China
关键词 曲马多 超前镇痛 腹腔镜胆囊切除术 Preemptive analgesia Tramadol hydrochloride Laparoscopic cholecystectomy
  • 相关文献

参考文献1

二级参考文献11

  • 1McArdle P. Intravenous analgesia. Crit Care Clin, 1999,15:89-104.
  • 2Bowdle TA. Adverse effects of opioid agonists and agonist-antagonists in anesthesia. Drug Saf, 1998,19:173-189.
  • 3Kehlet H, Dahl JB. The value of "multimodal" or "balanced analgesia"in postoperative pain treatment. Anesth Analg, 1993,77:1048-1056.
  • 4Power I, Barrett S. Analgesic agents for the postoperative period: nonopioids. Surg Clin North Am, 1999,79:275-295.
  • 5Tong D, Chung F. Postoperative pain control in ambulatory surgery. Surg Clin North Am, 1999,79:401-430.
  • 6Lipsky LP, Abramson SB, Crefford L, et al. The classification of cyclooxygenase inhibitors. J Rheumatol, 1998,25:2298-2303.
  • 7Penning TD, Talley JJ, Berteushaw SR, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenuse-2 inhihitors:identification of 4- [ 5- ( 4-methylphenyl ) -3- ( trifluoremethyl )- 1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). J Med Chem, 1997,40:1347-1365.
  • 8Tang J, Li S, White PF, et al. Effect of parecoxib, a novel intravenous cyclooxygenuse type-2 inhibitor, on the postoperative opioid requirement and quality of pain control. Anesthesiology, 2002,96: 1305-1309.
  • 9Malan TP Jr,Marsh G, Hakki SI, et al. Parecoxib sodium, a parenteral cyclooxygenuse 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty. Anesthesiology, 2003,98 :950-956.
  • 10Kranke P, Morin AM, Roewer N, et al. Patients' global evaluation of analgesia and safety of injected parecoxib for postoperative pain: a quantitative systematic review. Anesth Analg, 2004,99:797-806.

共引文献366

同被引文献25

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部